Trial intelligence / Profile preview

Evoprim vs Thioctic Acid in Diabetic Neuropathy

NCT03914404Phase 4Completed

Sponsor
Jeonbuk National University Hospital
Start
Jan 2016
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gamma-linolenic acid in diabetic neuropathy, sponsored by Jeonbuk National University Hospital. Started Jan 2016; status: completed.

02

Drugs

gamma-linolenic acid
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on NCT03914404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03914404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call